Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.
Gladstone DJ, Geerts WH, Douketis J, Ivers N, Healey JS, Leblanc K. Gladstone DJ, et al. Among authors: douketis j. Ann Intern Med. 2015 Sep 1;163(5):382-5. doi: 10.7326/M15-0143. Ann Intern Med. 2015. PMID: 26121536 No abstract available.
Deep vein thrombosis and its prevention in critically ill adults.
Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Attia J, et al. Among authors: douketis j. Arch Intern Med. 2001 May 28;161(10):1268-79. doi: 10.1001/archinte.161.10.1268. Arch Intern Med. 2001. PMID: 11371254 Review.
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. Crowther MA, et al. Among authors: douketis j. N Engl J Med. 2003 Sep 18;349(12):1133-8. doi: 10.1056/NEJMoa035241. N Engl J Med. 2003. PMID: 13679527 Free article. Clinical Trial.
Influence of warfarin on symptoms of fatigue: findings of a randomized trial.
Kovacs MJ, Kearon C, Julian JA, Douketis JD, Demers C, Wells PS, Turpie AG, Anderson DR, Kahn SR, Nguyen PV, Green D, Kassis J, Geerts W, Mackinnon B, Ginsberg JS. Kovacs MJ, et al. Among authors: douketis jd. Ann Pharmacother. 2005 May;39(5):840-2. doi: 10.1345/aph.1E531. Epub 2005 Mar 15. Ann Pharmacother. 2005. PMID: 15769830 Clinical Trial.
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.
Cook D, Douketis J, Meade M, Guyatt G, Zytaruk N, Granton J, Skrobik Y, Albert M, Fowler R, Hebert P, Pagliarello G, Friedrich J, Freitag A, Karachi T, Rabbat C, Heels-Ansdell D, Geerts W, Crowther M; Canadian Critical Care Trials Group. Cook D, et al. Among authors: douketis j. Crit Care. 2008;12(2):R32. doi: 10.1186/cc6810. Epub 2008 Mar 3. Crit Care. 2008. PMID: 18315876 Free PMC article.
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
Douketis J, Cook D, Meade M, Guyatt G, Geerts W, Skrobik Y, Albert M, Granton J, Hébert P, Pagliarello G, Marshall J, Fowler R, Freitag A, Rabbat C, Anderson D, Zytaruk N, Heels-Ansdell D, Crowther M; Canadian Critical Care Trials Group. Douketis J, et al. Arch Intern Med. 2008 Sep 8;168(16):1805-12. doi: 10.1001/archinte.168.16.1805. Arch Intern Med. 2008. PMID: 18779469 Clinical Trial.
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
Crowther MA, Cook DJ, Albert M, Williamson D, Meade M, Granton J, Skrobik Y, Langevin S, Mehta S, Hebert P, Guyatt GH, Geerts W, Rabbat C, Douketis J, Zytaruk N, Sheppard J, Greinacher A, Warkentin TE; Canadian Critical Care Trials Group. Crowther MA, et al. Among authors: douketis j. J Crit Care. 2010 Jun;25(2):287-93. doi: 10.1016/j.jcrc.2009.12.006. Epub 2010 Feb 10. J Crit Care. 2010. PMID: 20149589
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators. Healey JS, et al. Among authors: douketis j. Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Circulation. 2012. PMID: 22700854 Clinical Trial.
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.
Healey JS, Eikelboom J, Yang S, Themeles E, Connolly SJ, Yusuf S, Douketis J, Wallentin L, Oldgren J, Heidbuchel H, Avezum A, Reilly P, Ezekowitz M. Healey JS, et al. Among authors: douketis j. Circulation. 2013 Mar 19;127(11):e506. doi: 10.1161/circulationaha.112.154732. Circulation. 2013. PMID: 23646374 No abstract available.
417 results